[go: up one dir, main page]

ES2052105T3 - Gilanteno: principio anti-metastasico de sanguijuela de america del sur haementaria ghilianii. - Google Patents

Gilanteno: principio anti-metastasico de sanguijuela de america del sur haementaria ghilianii.

Info

Publication number
ES2052105T3
ES2052105T3 ES90111551T ES90111551T ES2052105T3 ES 2052105 T3 ES2052105 T3 ES 2052105T3 ES 90111551 T ES90111551 T ES 90111551T ES 90111551 T ES90111551 T ES 90111551T ES 2052105 T3 ES2052105 T3 ES 2052105T3
Authority
ES
Spain
Prior art keywords
ghilianii
sanguijuela
haementaria
gilanthene
metastatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90111551T
Other languages
English (en)
Inventor
Alan D Cardin
Sai Prasad Sunkara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2052105T3 publication Critical patent/ES2052105T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/856—Snakes; venom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/858—Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Road Paving Structures (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

UN METODO PARA INHIBIR LA METATASIS DE UN TUMOR, UTILIZA LA ADMINISTRACION DE UN FACTOR ANTIMETASTASICO AISLADO DEL HAEMENTERIA GHILIANII.
ES90111551T 1989-06-20 1990-06-19 Gilanteno: principio anti-metastasico de sanguijuela de america del sur haementaria ghilianii. Expired - Lifetime ES2052105T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36861689A 1989-06-20 1989-06-20
US43836589A 1989-12-14 1989-12-14

Publications (1)

Publication Number Publication Date
ES2052105T3 true ES2052105T3 (es) 1994-07-01

Family

ID=27004258

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90111551T Expired - Lifetime ES2052105T3 (es) 1989-06-20 1990-06-19 Gilanteno: principio anti-metastasico de sanguijuela de america del sur haementaria ghilianii.

Country Status (10)

Country Link
US (1) US5447911A (es)
EP (1) EP0404055B1 (es)
JP (1) JP2947882B2 (es)
KR (1) KR0185973B1 (es)
AT (1) ATE102041T1 (es)
AU (1) AU624962B2 (es)
DE (1) DE69006931T2 (es)
DK (1) DK0404055T3 (es)
ES (1) ES2052105T3 (es)
IE (1) IE63540B1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2047527A1 (en) * 1990-07-24 1992-01-25 Christopher Dunwiddie Method for administering a therapeutic anticoagulant
NZ270194A (en) * 1994-01-07 1996-05-28 Ciba Geigy Ag Hirustasin, a serine protease inhibitor from hirudo medicinalis
EP0662514A1 (en) * 1994-01-07 1995-07-12 Ciba-Geigy Ag Hirustasin, an antistasin type serine proteinase inhibitor from Hiruda
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
GB9930564D0 (en) 1999-12-23 2000-02-16 Evolutec Limited Screening method
US8004538B2 (en) 2007-09-21 2011-08-23 Global Oled Technology Llc Preferential tone scale for electronic displays
US8790711B2 (en) 2012-09-17 2014-07-29 Biopep Solutions, Inc. Treating diabetes with a whole, leech saliva extract
EP3038620A1 (en) * 2013-08-29 2016-07-06 Daiichi Sankyo Co., Ltd. Agent for the treatment and prevention of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390630A (en) * 1980-10-28 1983-06-28 The Regents Of The University Of California Hementin--a fibrinolytic agent
US4588587A (en) * 1983-03-01 1986-05-13 Pennsylvania Hospital Method of treatment to inhibit metastasis
IL83912A (en) * 1986-09-18 1993-05-13 Pennsylvania Hospital Protein having anticoagulant and antimetastatic properties
US4832849A (en) * 1988-06-16 1989-05-23 Merrell Dow Pharmaceuticals Inc. Extraction and purification of an anticoagulant principle from the south american leech, haementeria ghilianii

Also Published As

Publication number Publication date
DE69006931D1 (de) 1994-04-07
KR910000172A (ko) 1991-01-29
US5447911A (en) 1995-09-05
EP0404055B1 (en) 1994-03-02
JP2947882B2 (ja) 1999-09-13
AU624962B2 (en) 1992-06-25
EP0404055A1 (en) 1990-12-27
ATE102041T1 (de) 1994-03-15
AU5753890A (en) 1991-01-03
IE63540B1 (en) 1995-05-17
JPH03128326A (ja) 1991-05-31
IE902212L (en) 1990-12-20
KR0185973B1 (ko) 1999-05-01
DE69006931T2 (de) 1994-08-18
DK0404055T3 (da) 1994-03-28
IE902212A1 (en) 1991-01-16

Similar Documents

Publication Publication Date Title
FI882791L (fi) Aemnen som foerbaettrar det transdermala floedet av bestaemda 1,4-dihydropyridinderivat.
ES527776A0 (es) Procedimiento de preparacion de derivados de 1,4-dihidropiridinas.
FI900752A0 (fi) Maskin foer automatisk montering av en elastisk taetning, i synnerhet en yttre taetning, i en foensterspringa.
FI891407A (fi) Anordning foer svaellning av naeringsaemnen, njutningsmedel och liknande.
NO160444C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive imidazo-pyrazolo-pyrimidiner.
FI900870A0 (fi) Foerfarande foer belaeggning av papper med kompositioner, som innehaoller mikrokapslar.
FI892753A (fi) Hoejdregleringsanordning foer armstoed pao stolar, saerskilt rullstolar.
JPS53105477A (en) 7-glycylprolylamono-4-methylcoumarine
ES2052105T3 (es) Gilanteno: principio anti-metastasico de sanguijuela de america del sur haementaria ghilianii.
FI880454L (fi) Laosanordning, saerskilt foer en lucka till en dammsugare.
IT1164106B (it) Procedimento per la produzione di 14,15-derivati metilenici della serie d'estrano
FI884804L (fi) Foerfarande foer framstaellning av amino-1,3-benzendiol.
IT8820935A0 (it) Procedimento per la preparazione di 1,2,5,6,9,10 esabromociclododecano.
ES2021105B3 (es) Procedimiento para la obtencion de 5-amino-4,6-dihalogeno piridinas.
FI904348A0 (fi) Anordning foer paofoering av ett ytskikt pao ytan av ett i laengsriktningen roerligt foeremaol, i synnerhet medelst ett pulverformigt belaeggningsmaterial i kabelindustrin.
FI890266L (fi) Foerfarande foer framstaellning av affino-enzymatiska foereningar, vilka anvaends foer visuell bestaemning av kolesterol pao hudytan.
FI905872A0 (fi) Pelare foer uppbaerning av en platta, saosom en balkongplatta, pao en vaegg.
GR1001203B (el) Μεθοδος παρασκευης της ενωσεως 24r-σκυμνολη.
IT1230866B (it) Procedimento per la produzione di coke.
NO882028L (no) Fremgangsmaate for fremstilling av cardiotone, tricykliskeimidazoloner.
FI881241A0 (fi) Laettkonstruktionskaerna, saerskilt som stoedkaerna i skida.
ES520201A0 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina.
NO863045D0 (no) Fremgangsmaate for fremstilling av alkyl-2-karboalkoksy-3,4-dialkoksybenzenkarbamater.
JPS5399629A (en) Door
FI883957L (fi) Anordning foer kapning av traematerial till mindre stycken, t.ex. kapning av traedstammar till braennved.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 404055

Country of ref document: ES